Canadian evidence-based guidelines support the use of a cholinesterase inhibitor or memantine, or both drugs for the management of patients with severe Alzheimer's disease.
The U.S. National Cancer Institute recently announced it's sponsoring a study focused on the cold and flu fighting potential of COLD-Fx in leukemia patients.
New figures released by the Canadian Institute for Health Information indicate Canada's healthcare spending will hit $171.9 billion this year, an increase of 6.4% over 2007.